Best of LinkedIn: Health Tech CW 36/ 37

The past two weeks in health tech spotlighted AI’s deeper integration into cardiology, diagnostics, and monitoring, balanced by calls for governance and patient trust. Major investments, product launches, and cross-industry partnerships highlight a sector moving from experimentation to structured scale.

Date

September 3, 2025

Health Tech

Thomas Allgeyer

Methodology: Every two weeks we collect most relevant posts on LinkedIn for selected topics and create an overall summary only based on these posts. If you´re interested in the single posts behind, you can find them here: https://linktr.ee/thomasallgeyer. Have a great read!

‍

Listen to our podcast

AI strategy, regulation and trust

Leaders emphasise AI as a clinical amplifier designed for real problems, governed with evidence and accountability, and built for trust
Regulatory debates intensify in oncology and diagnostics, with calls to update medical device rules and strengthen testing frameworks for reliability
Commentary stresses an end to hype and a pivot to pragmatic value, including inclusive AI built on diverse data and a focus on outcomes over platforms
National ecosystem thinking advances, with secure, interoperable models promoted for broad adoption and European gaps in trust and infrastructure highlighted

‍

Clinical care, diagnostics and monitoring

Cardiology emerges as a key testbed, with clinician optimism for AI rising while patient confidence lags, pointing to a trust gap
Diagnostic AI gains traction, with activity in pathology, oncology, and imaging, supported by fresh funding and benchmark results
Sensor innovation progresses, with continuous monitoring of proteins, glucose, and inflammation framed as enablers of precision health
Clinician adoption is tied to solutions that demonstrably reduce time burden, mitigate alarm fatigue, and integrate seamlessly into workflows

‍

Corporate moves and investments

Enterprise players scale up, with multibillion-dollar commitments in medtech manufacturing, cloud infrastructure, and R&D expansion
Acquisitions strengthen virtual care, with Teladoc broadening specialty access through international integration
Strategic funding highlights public health priorities, including antimicrobial resistance and vaccine research backed by large-scale institutional investment
Market commentary positions infrastructure-led investment as critical, with AI demand expected to shape capital allocation strategies

‍

Product strategy and launches

Clinical tools are evaluated on their ability to reduce burden and free clinician time rather than novelty alone
Alarm management, workflow efficiency, and conversational AI pilots show how design choices directly affect adoption
Startups introduce innovations in diagnostics and monitoring, complementing enterprise-scale product moves
Emerging products increasingly measure success by outcomes delivered in care settings rather than technical sophistication

‍

Partnerships and ecosystem collaboration

Cloud providers, AI vendors, and health systems form new alliances to operationalise conversational AI and voice-enabled workflows
Public health partnerships gain recognition, with wastewater epidemiology advanced as a scalable early-warning capability
Multi-stakeholder collaborations are framed as essential for trust, data interoperability, and preparedness against systemic health threats
Partnerships reflect a sector shifting from siloed experimentation to coordinated ecosystem deployment

‍

Research, reports and benchmarks

The Philips Future Health Index snapshot provides insight into clinician optimism for AI and patient hesitancy, reinforcing the need for trust-building
Benchmark studies demonstrate high AI accuracy in specialty exams but highlight the importance of human oversight in deployment
Sensor research underlines the potential of continuous monitoring to reshape preventive and precision health
Academic and industry collaborations are positioned as key enablers of translational progress from lab to clinic

‍

Events and knowledge exchange

Global summits such as WHX Tech Dubai spotlight AI ethics, governance, and clinician impact, anchoring debate in real-world challenges
Panels and workshops emphasise the role of evidence-based implementation over speculative hype
Events are increasingly used as platforms to align regulators, providers, and vendors on standards and best practices
Knowledge exchange remains critical for bridging gaps between technical potential, clinical needs, and policy frameworks

‍

Workforce, design and adoption

Clinician trust remains the decisive adoption factor, with workflow integration and time savings as non-negotiable design criteria
Alarm fatigue and burnout are recognised as barriers, requiring AI to serve as a relief mechanism rather than an added burden
Workforce commentary highlights the risk of uneven adoption if patient trust gaps are not addressed alongside clinician buy-in
Design frameworks increasingly emphasise co-creation with practitioners to ensure alignment of technology with daily care delivery

‍

Subscribe to newsletter

Subscribe to receive the latest blog posts to your inbox every week.